Tenor Capital Management »

Haemonetics shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Haemonetics shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Haemonetics

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $27B 30M 892.36

More positions owned by Tenor Capital Management

Palo Alto Networks Note 0.375% 6/0 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Block Note 0.125% 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Alteryx Note 0.500% 8/0 (Principal)
Five9 Note 0.500% 6/0 (Principal)
Mongodb Note 0.250% 1/1 (Principal)
Liberty Media Corp Note 2.750% 12/0 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Ati Note 3.500% 6/1 (Principal)
Evolent Health Note 1.500%10/1 (Principal)
Hubspot Note 0.375% 6/0 (Principal)

View all positions for Tenor Capital Management

Top funds holding Haemonetics

Franklin Resources
Readystate Asset Management
Tenor Capital Management
MacKay Shields
DeepCurrents Investment Group
Wolverine Asset Management
Aviva
Aequim Alternative Investments
Wells Fargo & Company
Osterweis Capital Management
Empyrean Capital Partners
Context Capital Management
D. E. Shaw & Co
Bnp Paribas Investment Partners
New York State Common Retirement Fund

View all funds holding Haemonetics